Adicet Bio, Inc.

ACET · Nasdaq · SIC 2834: Pharmaceutical Preparations
209
SEC Filings

Business Summary

5 Item 1A. Risk Factors 37 Item 1B. Unresolved Staff Comments 95 Item 1C. Cybersecurity 95 Item 2. Properties 95 Item 3. Legal Proceedings 96 Item 4. Mine Safety Disclosures 96 PART II 97 Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 97 Item 6. [ Reserved ] 97 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 98 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 106 I...

Next Earnings

Q2 FY2026 — expected 2026-08-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionACETdiscussed_in_filing Cybersecurity
topic_mentionACETdiscussed_in_filing Cybersecurity
topic_mentionACETdiscussed_in_filing Cybersecurity
topic_mentionACETdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001720580-26-000008EDGAR103K words
2025-03-062024-12-310000950170-25-034587EDGAR—
2024-03-192023-12-310000950170-24-033482EDGAR—
2023-03-152022-12-310000950170-23-008130EDGAR—
2022-03-152021-12-310000950170-22-003753EDGAR—
2021-03-122020-12-310001564590-21-012664EDGAR—
2020-03-122019-12-310001564590-20-010474EDGAR—
2019-03-182018-12-310001564590-19-008262EDGAR—
2018-03-292017-12-310001564590-18-007150EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-266880EDGAR71K words
2025-08-072025-06-300000950170-25-104978EDGAR—
2025-05-062025-03-310000950170-25-064448EDGAR—
2024-11-062024-09-300000950170-24-122253EDGAR—
2024-08-132024-06-300000950170-24-095745EDGAR—
2024-05-142024-03-310000950170-24-059507EDGAR—
2023-11-082023-09-300000950170-23-061128EDGAR—
2023-08-092023-06-300000950170-23-040631EDGAR—
2023-05-092023-03-310000950170-23-019700EDGAR—
2022-11-082022-09-300000950170-22-023230EDGAR—
2022-08-102022-06-300000950170-22-016254EDGAR—
2022-05-122022-03-310000950170-22-009690EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-120001720580-26-000006EDGAR2K words
2026-01-070001193125-26-005486EDGAR—
2025-12-290001193125-25-332343EDGAR—
2025-12-190001193125-25-326784EDGAR—
2025-11-050001193125-25-266860EDGAR—
2025-10-070001193125-25-233427EDGAR—
2025-10-070001193125-25-232558EDGAR—
2025-10-070001193125-25-232539EDGAR—
2025-08-070000950170-25-104969EDGAR—
2025-07-230000950170-25-097881EDGAR—

209 total filings indexed. 178 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001720580
TickerACET
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f8a226c870fa38bf76ab73a9caf6553b75861a2d9f27005202f347f749ed9c54
parent: e4b0b071b3f8d25c9076060f198ddcc0ad1df6708e3cdbb60a9353a7e93b3bf5
content hash: 121cb446a57984bcc9f20bdfcec047eebd7fef7523bc0bdbcb2210217f5d86de
signed: 2026-04-13T04:43:26.132Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf